Autres langues Surgery Partners, Inc.

Actions

SGRY

US86881A1007

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 22/04/2024			Varia. 5j.	Varia. 1 janv.
24,04 ^USD	+0,88 %		-6,35 %	-24,85 %

26/03	L'unité Surgery Partners va offrir 600 millions de dollars de billets de premier rang	MT
06/03	Un initié de Surgery Partners a vendu des actions pour une valeur de 277 633 $, selon un récent dépôt auprès de la SEC	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Surgery Partners, Inc. Announces First Quarter 2024 Earnings Release Date and Conference Call Details	18/04
Surgery Partners Unit to Offer $600 Million of Senior Notes	26/03
Surgery Partners, Inc. Announces New Senior Notes Offering	26/03
Surgery Partners Insider Sold Shares Worth $277,633, According to a Recent SEC Filing	06/03
Surgery Partners Q4 Adjusted Earnings, Revenue Climb	26/02
Earnings Flash (SGRY) SURGERY PARTNERS Posts Q4 EPS $0.44, vs. Street Est of $0.38	26/02
Surgery Partners: Q4 Earnings Snapshot	26/02
Surgery Partners, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	26/02
Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2023 Results; Sets 2024 Guidance	26/02
Surgery Partners, Inc. Provides Earnings Guidance for the Year 2024	26/02
Surgery Partners, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	26/02
North American Morning Briefing : Traders Await -2-	26/02
Surgery Partners, Inc. Announces Fourth Quarter 2023 Earnings Release Date and Conference Call Details	08/02
Certain Stock Options of Surgery Partners, Inc. are subject to a Lock-Up Agreement Ending on 29-JAN-2024.	29/01
Certain Common Stock of Surgery Partners, Inc. are subject to a Lock-Up Agreement Ending on 29-JAN-2024.	29/01
Sheridan Capital Partners-Backed Oral Surgery Partners Announces $400M Credit Expansion, Multiple Acquisitions, and C-Suite Hires	23/01
Surgery Partners Seeks M&A	08/01
Surgery Partners Reiterates 2023 Revenue Outlook of $2.75 Billion	08/01
Surgery Partners, Inc. Reaffirms 2023 Full Year Guidance and Provides 2024 Initial Adjusted EBITDA Outlook	08/01
Surgery Partners, Inc. Reaffirms Earnings Guidance for the Year 2023	08/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Surgery Partners, Inc.

Actions

SGRY

US86881A1007

Autres langues

Filtres